combination therapies for the treatment of hepatocellular carcinoma

• 收藏
• 分享

专利权人:

EISAI R & D MANAGEMENT CO.; LTD.

发明人:

ANAND SELVARAJ,PETER SMITH

申请号：

BR112019003722

公开号：

BR112019003722A2

申请日:

2017.08.23

申请国别(地区):

BR

年份:

2019

代理人:

摘要：

Combination therapy useful for the treatment of hepatocellular carcinoma and / or intrahepatic cholangiocarcinoma is provided herein. the combination comprises an fgfr4 inhibitor and a cdk 4/6 inhibitor.é fornecida aqui uma terapia de combinação útil para o tratamento de carcinoma hepatocelular e/ou colangiocarcinoma intra-hepático. a combinação compreende um inibidor fgfr4 e um inibidor cdk 4/6.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/